Duration of antifungal therapy for septic pulmonary embolism caused by Candida albicans from a central venous catheter: A case report
暂无分享,去创建一个
Y. Obase | K. Yanagihara | H. Mukae | T. Miyazaki | Y. Imamura | K. Izumikawa | N. Sakamoto | H. Yamaguchi | T. Takazono | Kazuko Yamamoto | N. Ashizawa | Kazuhiro Oshima | T. Hirayama | D. Okuno | Tomomi Saijo
[1] Jin-liang Kong,et al. Septic pulmonary embolism in China: clinical features and analysis of prognostic factors for mortality in 98 cases , 2019, BMC Infectious Diseases.
[2] Rachel M. Kenney,et al. T2 Candida versus beta-D-glucan to facilitate antifungal discontinuation in the intensive care unit. , 2019, Diagnostic microbiology and infectious disease.
[3] B. Kullberg,et al. Invasive Candidiasis. , 2019, The New England journal of medicine.
[4] I. Raad,et al. Appropriate Duration of Intravenous Treatment of Candidemia and Timing of Step Down to Oral Therapy in Non-neutropenic Patients , 2018, Mediterranean journal of hematology and infectious diseases.
[5] Rui Xia,et al. Evaluation of candidemia in epidemiology and risk factors among cancer patients in a cancer center of China: an 8-year case-control study , 2017, BMC Infectious Diseases.
[6] J. Sobel,et al. Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] J. Sobel,et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] C. Clancy,et al. Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] G. Fadda,et al. Biofilm Production by Candida Species and Inadequate Antifungal Therapy as Predictors of Mortality for Patients with Candidemia , 2007, Journal of Clinical Microbiology.
[10] K. Garey,et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Victoria J. Fraser,et al. Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality , 2005, Antimicrobial Agents and Chemotherapy.
[12] G. Aughenbaugh,et al. Septic pulmonary embolism: presenting features and clinical course of 14 patients. , 2005, Chest.
[13] S. Fridkin,et al. Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003 , 2005, Journal of Clinical Microbiology.
[14] B. Kullberg,et al. Invasive Candidiasis. , 2015, The New England journal of medicine.
[15] R. Ye,et al. Clinical characteristics of septic pulmonary embolism in adults: a systematic review. , 2014, Respiratory medicine.